Observational studyCritical care (London, England)2025
Hormonal response following hemorrhage after severe trauma: an observational prospective study.
Observational study in Critical care (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hemodynamic rescue after blast injury: intravenous administration outperforms intramuscular vasopressin in a swine model.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026Article
- Neuroendocrine responses to hemorrhagic shock in severe trauma: unraveling controversies and therapeutic implications.Critical care (London, England) · 2026Article
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFollowing severe trauma, activation of the autonomic and neuroendocrine systems is key in the response to hemorrhage by triggering vasopressor secretion, sodium and water reabsorption to maintain blood pressure and organ perfusion. However, these adaptative mechanisms remain not yet well described in this setting. The main goal of this study was to explore hypothalamic-posterior-pituitary-vasopressin, hypothalamic–pituitary–adrenal and renin–angiotensin–aldosterone system responses to severe trauma.
methodsThis is a single-centre prospective observational study among adult severe trauma patients (Injury Severity Score (ISS) ≥ 9) in a French level-1 trauma center.
resultsSixty-five patients were included with a mean age of 46 (± 20) years old and a median ISS of 25 (19–30). Twenty-eight (43%) patients presented with a hemorrhage (transfusion of at least one pack of red blood cells (pRBC) in the 6 first hours), and 15 (23%) of them had a severe hemorrhage (> 3 pRBC in the first 6 h). Evolution of copeptin level, reflecting vasopressin secretion, was significantly different over the 48 h between transfused and non-transfused patients (interaction; P < 0.001) and regarding hemorrhage severity (no transfusion, 1–3 pRBC, > 3 pRBC) (interaction; P < 0.001). Copeptin was maximum at admission and higher in transfused than in non-transfused patients (486 ± 433 pmol/L vs.208 ± 206 pmol/L; P < 0.001). It rapidly decreased without significant difference anymore between groups from 6 h after admission. Renin (time effect, P = 0.001; transfusion effect, P = 0.02; interaction, P = 0.04) and aldosterone (time effect, P < 0.001; transfusion effect, P = 0.7; interaction, P = 0.08) were significantly different over the first 48 h regarding hemorrhage severity. There was no difference between transfused and non-transfused patients regarding levels of cortisol (P = 0.06). Twenty-two patients presented a relative corticosteroid insufficiency and 44 presented mineralocorticoid deficiency (aldosterone/renin < 2) over the first 48 h.
conclusionsThe vasopressin and renin–angiotensin–aldosterone systems are key pathways in the response to hemorrhage following severe trauma, and their response is quickly exhausted with its severity. This study strengthens the pathophysiological rationale for exploring personalized vasopressor management, including the timely addition of vasopressin and/or angiotensin II in addition to norepinephrine during the resuscitation of traumatic hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.